Phytochemicals and Gastrointestinal Cancer: Cellular Mechanisms and Effects to Change Cancer Progression

Published on Jan 8, 2020
· DOI :10.3390/BIOM10010105
Raghad Khalid AL-Ishaq2
Estimated H-index: 2
(Qatar Foundation),
Anthony J. Overy1
Estimated H-index: 1
(Qatar Foundation),
Dietrich Büsselberg33
Estimated H-index: 33
(Qatar Foundation)
Gastrointestinal (GI) cancer is a prevailing global health disease with a high incidence rate which varies by region. It is a huge economic burden on health care providers. GI cancer affects different organs in the body such as the gastric organs, colon, esophagus, intestine, and pancreas. Internal and external factors like smoking, obesity, urbanization, genetic mutations, and prevalence of Helicobacter pylori and Hepatitis B and Hepatitis C viral infections could increase the risk of GI cancer. Phytochemicals are non-nutritive bioactive secondary compounds abundantly found in fruits, grains, and vegetables. Consumption of phytochemicals may protect against chronic diseases like cardiovascular disease, neurodegenerative disease, and cancer. Multiple studies have assessed the chemoprotective effect of selected phytochemicals in GI cancer, offering support to their potential towards reducing the pathogenesis of the disease. The aim of this review was to summarize the current knowledge addressing the anti-cancerous effects of selected dietary phytochemicals on GI cancer and their molecular activities on selected mechanisms, i.e., nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), detoxification enzymes, adenosine monophosphate activated protein kinase (AMPK), wingless-related integration site/β-catenin (wingless-related integration site (Wnt) β-catenin, cell apoptosis, phosphoinositide 3-kinases (PI3K)/ protein kinase B AKT/ mammalian target of rapamycin (mTOR), and mitogen-activated protein kinase (MAPK). In this review phytochemicals were classified into four main categories: (i) carotenoids, including lutein, lycopene, and β-carotene; (ii) proanthocyanidins, including quercetin and ellagic acid; (iii) organosulfur compounds, including allicin, allyl propyl disulphide, asparagusic acid, and sulforaphane; and (iv) other phytochemicals including pectin, curcumins, p-coumaric acid and ferulic acid. Overall, phytochemicals improve cancer prognosis through the downregulation of β-catenin phosphorylation, therefore enhancing apoptosis, and upregulation of the AMPK pathway, which supports cellular homeostasis. Nevertheless, more studies are needed to provide a better understanding of the mechanism of cancer treatment using phytochemicals and possible side effects associated with this approach.
Figures & Tables
  • References (224)
  • Citations (2)
#1Afsane Bahrami (Birjand University of Medical Sciences)H-Index: 18
#2Muhammed MajeedH-Index: 6
Last. Amirhossein Sahebkar (MUMS: Mashhad University of Medical Sciences)H-Index: 68
view all 3 authors...
Background Epithelial-to-mesenchymal transition (EMT) is involved in tumor progression, invasion, migration and metastasis. EMT is a process by which polarized epithelial cells acquire motile mesothelial phenotypic features. This process is initiated by disassembly of cell-cell contacts through the loss of epithelial markers and replacement of these markers by mesenchymal markers. Reconstruction of the cytoskeleton and degradation of the tumor basement membrane ensures the spread of invasive mal...
3 CitationsSource
#1Gisela Ibáñez-Redín (USP: University of São Paulo)H-Index: 4
#2Roberto H.M. Furuta (USP: University of São Paulo)H-Index: 1
Last. Osvaldo N. Oliveira-Jr (USP: University of São Paulo)H-Index: 46
view all 12 authors...
Abstract Nanostructured capacitive biosensors, combined with inexpensive fabrication technologies, may provide simple, sensitive devices for detecting clinically relevant cancer biomarkers. Herein, we report a novel platform for detecting the pancreatic cancer biomarker CA19-9 using low-cost screen-printed interdigitated electrodes (SPIDEs). The SPIDEs were modified by carbon nano-onions (CNOs) and graphene oxide (GO) films, on which a layer of anti-CA19-9 antibodies was immobilized. The modific...
1 CitationsSource
Colorectal cancer (CRC) is among the top three cancer with higher incident and mortality rate worldwide. It is estimated that about over than 1.1 million of death and 2.2 million new cases by the year 2030. The current treatment modalities with the usage of chemo drugs such as FOLFOX and FOLFIRI, surgery and radiotherapy, which are usually accompanied with major side effects, are rarely cured along with poor survival rate and at higher recurrence outcome. This trigger the needs of exploring new ...
#1Jimi KimH-Index: 1
#2Jeonghee LeeH-Index: 12
Last. Kwang Woon KimH-Index: 61
view all 8 authors...
It is unclear whether dietary lutein/zeaxanthin intake in colorectal cancer is associated with microRNA processing involved in DICER1 cleavage for messenger RNA translation. We investigated whether dietary lutein/zeaxanthin intake affects colorectal cancer risk in patients with a DICER1 rs3742330 polymorphism. In this hospital-based case-control study, we recruited 923 colorectal cancer patients and 1,846 controls based on eligibility criteria, a semiquantitative food frequency questionnaire and...
#1Bridget A. BaxterH-Index: 1
#2Renee C. OppelH-Index: 2
Last. Elizabeth P. RyanH-Index: 36
view all 3 authors...
Colorectal cancer (CRC) is the third leading cause of cancer-related death in the United States and emerging evidence supports that increased consumption of legumes, such as navy beans, can reduce risk. Navy bean consumption was previously shown to modulate host and microbiome metabolism, and this investigation was performed to assess the impact on the human stool metabolome, which includes the presence of navy bean metabolites. This 4-week, randomized-controlled trial with overweight and obese ...
3 CitationsSource
#1Yanyan LiH-Index: 14
#2Tao ZhangH-Index: 21
Last. Grace Y. ChenH-Index: 1
view all 3 authors...
Colorectal cancer (CRC) is the third most common cancer, but despite advances in treatment, it remains the second most common cause of cancer-related mortality. Prevention may, therefore, be a key strategy in reducing colorectal cancer deaths. Given reports of an inverse association between fruit and vegetable consumption with colorectal cancer risk, there has been significant interest in understanding the metabolism and bioactivity of flavonoids, which are highly abundant in fruits and vegetabl...
4 CitationsSource
#1Nabarun Roy (Kerala Agricultural University)H-Index: 3
#2P. A. Nazeem (Kerala Agricultural University)H-Index: 6
Last. Achuthan C. Raghavamenon (University of Calicut)H-Index: 6
view all 8 authors...
Colorectal cancer is one among the most common cancers in the world and a major cause of cancer related deaths. Similar to other cancers, colorectal carcinogenesis is often associated with over expression of genes related to cell growth and proliferation, especially Epidermal Growth Factor Receptor (EGFR). There is an increasing attention towards the plant derived compounds in prevention of colorectal carcinogenesis by downregulating EGFR. Among plants, garlic (Allium sativum L.) is emerging wit...
4 CitationsSource
#1Xian Wu (UMass: University of Massachusetts Amherst)H-Index: 13
#2Mingyue Song (UMass: University of Massachusetts Amherst)H-Index: 15
Last. Hang Xiao (UMass: University of Massachusetts Amherst)H-Index: 53
view all 9 authors...
SCOPE: There are growing interests in using a whole-food-based approach to prevent chronic diseases due to potential synergistic interactions among different bioactive components within the whole foods. North American cranberry (Vaccinium macrocarpon), a polyphenol-rich fruit, has been shown to exert multiple beneficial health effects. METHODS AND RESULTS: For the first time, the protective effects of whole cranberry powder (WCP) are determined against colitis-associated mouse colon tumorigenesi...
2 CitationsSource
#1Freddie Ian Bray (IARC: International Agency for Research on Cancer)H-Index: 91
#2Jacques Ferlay (IARC: International Agency for Research on Cancer)H-Index: 65
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 110
view all 6 authors...
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer...
3,723 CitationsSource
#1Sara Jaramillo-Carmona (CSIC: Spanish National Research Council)H-Index: 6
#2Rafael Guillén (CSIC: Spanish National Research Council)H-Index: 27
Last. Sergio López (University of Seville)H-Index: 18
view all 5 authors...
: Colorectal cancer is the third most common cancer in the world. Many efforts have focused on finding natural molecules with potential chemo-preventive activity due to their low toxicity compared to synthetic drugs. However, comprehensive information on the bioactive fractions and components is still missing. In this study, we developed a method for the quantitative separation and isolation of saponins from asparagus genotypes consisting of an adsorption chromatography and subsequent liquid chr...
1 CitationsSource
Cited By2
#1Tiffany L. Weir (CSU: Colorado State University)H-Index: 31
#2S. Raj J. Trikha (CSU: Colorado State University)H-Index: 1
Last. Henry J. Thompson (CSU: Colorado State University)H-Index: 55
view all 3 authors...
Abstract According to recent estimates, over one third of the human population will be diagnosed with cancer at some point in their lifetime. While genetic factors play a large part in cancer risk, as much as 50% of cancers may be preventable through various lifestyle modifications. Nutrition is a major modifiable risk factor, both through its impacts on obesity as well as through dietary chemical exposures that can either increase or decrease cancer risk. However, specific associations and mech...
#1Sumeet S. Chauhan (University of Texas at Austin)H-Index: 1
Last. Murali M. Yallapu (University of Texas at Austin)H-Index: 2
view all 5 authors...
Pancreatic cancer (PanCa) is a lethal disease. Conventional chemotherapies for PanCa offer severe systemic toxicities. Thus, the development of a successful nanomedicine-based therapeutic regimen with augmented therapeutic efficacy is highly sought. Naturally occurring pectin and modified pectin-based drug delivery systems exhibit remarkable self-targeting ability via galactose residues to various cancer cells. Herein, we developed and used an innovative approach of highly stable nanocomplexes b...